As of 2026-04-07, the Relative Valuation of Revolution Medicines Inc (RVMD) is (105.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 95.36 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -210.3%.
The range of the Relative Valuation is (100.97) - (114.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 26.3x | 23.9x |
| Forward P/E multiples | 21.1x - 24.8x | 21.5x |
| Fair Price | (100.97) - (114.87) | (105.14) |
| Upside | -205.9% - -220.5% | -210.3% |
| Date | P/E |
| 2026-04-06 | -20.59 |
| 2026-04-02 | -21.40 |
| 2026-04-01 | -21.30 |
| 2026-03-31 | -21.00 |
| 2026-03-30 | -20.02 |
| 2026-03-27 | -19.97 |
| 2026-03-26 | -20.12 |
| 2026-03-25 | -20.36 |
| 2026-03-24 | -20.62 |
| 2026-03-23 | -20.86 |
| 2026-03-20 | -20.68 |
| 2026-03-19 | -21.44 |
| 2026-03-18 | -21.18 |
| 2026-03-17 | -21.40 |
| 2026-03-16 | -21.37 |
| 2026-03-13 | -20.48 |
| 2026-03-12 | -20.53 |
| 2026-03-11 | -21.50 |
| 2026-03-10 | -21.34 |
| 2026-03-09 | -21.54 |
| 2026-03-06 | -21.24 |
| 2026-03-05 | -21.51 |
| 2026-03-04 | -21.85 |
| 2026-03-03 | -21.70 |
| 2026-03-02 | -21.94 |
| 2026-02-27 | -22.03 |
| 2026-02-26 | -22.05 |
| 2026-02-25 | -22.29 |
| 2026-02-24 | -22.63 |
| 2026-02-23 | -22.39 |
| 2026-02-20 | -21.98 |
| 2026-02-19 | -22.18 |
| 2026-02-18 | -21.54 |
| 2026-02-17 | -21.72 |
| 2026-02-13 | -20.79 |
| 2026-02-12 | -21.01 |
| 2026-02-11 | -21.16 |
| 2026-02-10 | -20.72 |
| 2026-02-09 | -20.89 |
| 2026-02-06 | -21.05 |
| 2026-02-05 | -20.76 |
| 2026-02-04 | -20.84 |
| 2026-02-03 | -20.72 |
| 2026-02-02 | -20.98 |
| 2026-01-30 | -20.93 |
| 2026-01-29 | -21.20 |
| 2026-01-28 | -21.01 |
| 2026-01-27 | -21.55 |
| 2026-01-26 | -21.11 |
| 2026-01-23 | -25.40 |